0001125345-20-000098.txt : 20200521 0001125345-20-000098.hdr.sgml : 20200521 20200521194439 ACCESSION NUMBER: 0001125345-20-000098 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200520 FILED AS OF DATE: 20200521 DATE AS OF CHANGE: 20200521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Spitznagel Thomas CENTRAL INDEX KEY: 0001675464 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36112 FILM NUMBER: 20903378 MAIL ADDRESS: STREET 1: 9704 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MACROGENICS INC CENTRAL INDEX KEY: 0001125345 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9704 MEDICAL CENTER DRIVE CITY: Rockville STATE: MD ZIP: 20850 BUSINESS PHONE: 301-251-5172 MAIL ADDRESS: STREET 1: 9704 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 wf-form4_159010466198723.xml FORM 4 X0306 4 2020-05-20 0 0001125345 MACROGENICS INC MGNX 0001675464 Spitznagel Thomas 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 0 1 0 0 Sr VP, BPD & Manufacturing Common Stock 2020-05-20 4 M 0 7500 7.51 A 7500 D Common Stock 2020-05-20 4 S 0 7500 25.30 D 0 D Employee stock option (right to buy) 7.51 2020-05-20 4 M 0 7500 0 D 2014-03-18 2023-09-17 Common Stock 7500.0 54647 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2020. This transaction was executed in multiple trades at prices ranging from $24.86 to $25.78. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. 12.5% of the shares underlying the grant became exercisable on the date reflected and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter. /s/ Lynn Cilinski, Attorney-in-Fact 2020-05-21